Can Tests Reveal a CLL Patient’s Potential for Developing Treatment Resistance?

Published on

Topics include: Ask the Expert

Patient Power community member Theresa writes in, “Although my husband is doing well, is there testing to know whether he will develop treatment resistance in the future?” During this Ask the Expert segment, renowned chronic lymphocytic leukemia (CLL) expert Dr. Richard Furman, from Weill Cornell Medicine, responds by sharing research on CLL patients with mutations and clinical relapse. Watch now to learn more.

This is a Patient Empowerment Network program produced by Patient Power. We thank AbbVie, Inc. and Pharmacyclics for their support.

View more programs featuring and

Produced in association with

Transcript

And, two, is you really—you know, in essence when you look at the data that suggests that 92 percent of patients who get ibrutinib (Imbruvica) as a first-line therapy will remain in remission at five years you're talking about treating--or testing a lot of people for very, very few people that will likely benefit.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

What Options Are Available for CLL Patients Who Relapse After Ibrutinib?

What can be done when a CLL patient relapses on ibrutinib? Watch as CLL expert Dr. Richard Furman explains potential progression factors and treatment options.

Published:

CLL Prognosis: What Can Genetic Testing Reveal About Progression?

What diagnostic testing is important for CLL patients? How do genetic mutations impact prognosis, disease behavior and treatment decisions? Watch now to hear recommendations from a panel of experts.

Published:

Mark’s CLL Journey: FCR to Combination Therapies to Transplant

CLL patient and advocate Mark Silverstein shares his experience with several different therapies and the unanticipated challenges he faced on his treatment journey.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on September 9, 2019